Dr. Lisa Cillessen, Clinical Assistant Professor for the UMKC School of Pharmacy, was recently featured in a story by Kansas City Fox4 on the development of monoclonal antibody infusions in the ongoing fight against COIVD-19.
This outpatient treatment strategy is administered to symptomatic patients with mild to moderate cases of COVID-19 and is designed to keep individuals from progressing to the point where they would need to be hospitalized. These infusions save resources and have proven successful in helping to curb community spread. As of August 13th, 423 patients have received the treatment.
"Dr. Cillessen has been instrumental in setting up infusion centers... she has been working tirelessly to expand the services and assist in logistics and identifying patients", says Dr. Paul O. Gubbins, Associate Dean for the UMKC School of Pharmacy.
Dr. Cillessen is a board-certified ambulatory care pharmacist and practices at Jordan Valley Community Health Center, providing chronic disease management services to the uninsured and underinsured.
The full video from Fox4 can be viewed below.
